Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$34,664,801
+$15,148,706 QoQ
Shares Held
205,677
+38.8% QoQ
Ownership
0.202%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#82
of 768 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $207,447,311 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
111,326 | $60,319,766 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,326,678 | $44,947,850 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
205,677 | $34,664,801 | |
| 4 | VTRS |
Viatris Inc
|
1,698,341 | $26,969,655 | |
| 5 | ZTS |
Zoetis Inc.
|
134,203 | $9,643,827 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
65,941 | $7,315,494 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
491,057 | $4,910,570 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
866,285 | $4,270,785 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,664,801 | 205,677 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $19,516,095 | 148,141 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $21,273,081 | 149,990 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,234,074 | 23,038 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,124,045 | 8,943 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $9,648,522 | 87,238 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $45,399,627 | 332,598 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $15,576,130 | 135,186 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,052,733 | 87,548 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,192,985 | 23,151 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,097,018 | 23,505 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,186,937 | 54,995 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,202,059 | 55,165 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,993,236 | 59,210 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $633,912 | 6,503 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $470,625 | 5,020 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $215,224 | 2,527 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $306,624 | 3,197 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $577,496 | 5,934 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||